vinpocetine has been researched along with Aging in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cselényi, Z; Gulyás, B; Halldin, C; Mattsson, P; Schain, M; Takano, A; Tóth, M; Varrone, A; Vas, A | 1 |
| Araki, H; Hashimoto-Kitsukawa, S; Imagawa, Y; Kawashima, K; Kawashima, Y; Ogawa, S; Okuyama, S; Otomo, S | 1 |
| Kárpáti, E; Kiss, B; Paróczai, M | 1 |
| Blaschke, M; Fischer, HD; Rudolph, E; Schmidt, J; Wustmann, C | 1 |
| Beitinger, H; Braun, W; Grandt, R; Schaltenbrand, R | 1 |
| Burtsev, EM; Savkov, VS; Shprakh, VV | 1 |
| Man'kovsky, NB; Minz, AY | 1 |
| Göndöc, C; Miskolczi, P; Szalay, L; Vereczkey, L | 1 |
8 other study(ies) available for vinpocetine and Aging
| Article | Year |
|---|---|
Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Data Interpretation, Statistical; Female; Humans; Image Processing, Computer-Assisted; Isotope Labeling; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA; Vinca Alkaloids | 2011 |
Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats.
Topics: Aging; Animals; Arousal; Avoidance Learning; Behavior, Animal; Caudate Nucleus; Cerebrovascular Circulation; Corpus Striatum; Electric Stimulation; Electroencephalography; Male; Rats; Rats, Wistar; Vasodilator Agents; Vinca Alkaloids | 1994 |
Effect of RGH-2716 on learning and memory deficits of young and aged rats in water-labyrinth.
Topics: Aging; Amnesia, Retrograde; Animals; Diazepam; Learning Disabilities; Male; Maze Learning; Memory; Memory Disorders; Neuroprotective Agents; Nimodipine; Rats; Rats, Inbred F344; Rats, Inbred SHR; Rats, Wistar; Scopolamine; Spiro Compounds; Swimming; Vinca Alkaloids | 1998 |
Influence of nootropic drugs on the age-dependent potassium-coupling of transmitter release.
Topics: Aging; Animals; Calcium-Transporting ATPases; Dopamine; Dose-Response Relationship, Drug; Meclofenoxate; Piracetam; Potassium; Psychotropic Drugs; Rats; Rats, Inbred Strains; Synaptosomes; Vasodilator Agents; Vinca Alkaloids | 1990 |
Vinpocetine pharmacokinetics in elderly subjects.
Topics: Administration, Oral; Aged; Aging; Blood Cell Count; Blood Pressure; Creatinine; Electrocardiography; Female; Heart Rate; Hematocrit; Humans; Injections, Intravenous; Male; Middle Aged; Vinca Alkaloids | 1989 |
[Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Drug Evaluation; Female; Humans; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Vasodilator Agents; Vinca Alkaloids | 1988 |
Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
Topics: Aged; Aging; Arteriosclerosis; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Electroencephalography; Evoked Potentials, Visual; Humans; Mental Processes; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1988 |
Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
Topics: Adult; Aged; Aging; Blood Proteins; Humans; Infusions, Intravenous; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1987 |